XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in-Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2022 $ 3 $ 249,056 $ (227,228) $ 21,831
Beginning balance (in shares) at Dec. 31, 2022 3,472,246      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 325 0 325
Issuance of restricted stock $ 0 0 0 0
Issuance of restricted stock (in shares) 15,835      
Net loss $ 0 0 (2,835) (2,835)
Ending balance at Mar. 31, 2023 $ 3 249,381 (230,063) 19,321
Ending balance (in shares) at Mar. 31, 2023 3,488,081      
Beginning balance at Dec. 31, 2022 $ 3 249,056 (227,228) 21,831
Beginning balance (in shares) at Dec. 31, 2022 3,472,246      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (7,036)
Ending balance at Sep. 30, 2023 $ 3 250,454 (234,264) 16,193
Ending balance (in shares) at Sep. 30, 2023 3,491,324      
Beginning balance at Mar. 31, 2023 $ 3 249,381 (230,063) 19,321
Beginning balance (in shares) at Mar. 31, 2023 3,488,081      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 352 0 352
Modification of common stock warrants 0 384 0 384
Net loss 0 0 (3,148) (3,148)
Ending balance at Jun. 30, 2023 $ 3 250,117 (233,211) 16,909
Ending balance (in shares) at Jun. 30, 2023 3,488,081      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 337 0 337
Issuance of restricted stock $ 0 0 0 0
Issuance of restricted stock (in shares) 3,243      
Net loss $ 0 0 (1,053) (1,053)
Ending balance at Sep. 30, 2023 $ 3 250,454 (234,264) 16,193
Ending balance (in shares) at Sep. 30, 2023 3,491,324      
Beginning balance at Dec. 31, 2023 $ 4 250,742 (238,058) 12,688
Beginning balance (in shares) at Dec. 31, 2023 3,506,025      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 112 0 112
Net loss 0 0 (3,368) (3,368)
Ending balance at Mar. 31, 2024 $ 4 250,854 (241,426) 9,432
Ending balance (in shares) at Mar. 31, 2024 3,506,025      
Beginning balance at Dec. 31, 2023 $ 4 250,742 (238,058) 12,688
Beginning balance (in shares) at Dec. 31, 2023 3,506,025      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (5,589)
Ending balance at Sep. 30, 2024 $ 4 252,986 (243,647) 9,343
Ending balance (in shares) at Sep. 30, 2024 4,171,161      
Beginning balance at Mar. 31, 2024 $ 4 250,854 (241,426) 9,432
Beginning balance (in shares) at Mar. 31, 2024 3,506,025      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 163 0 163
Net loss 0 0 (99) (99)
Ending balance at Jun. 30, 2024 $ 4 251,017 (241,525) 9,496
Ending balance (in shares) at Jun. 30, 2024 3,506,025      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 26 0 26
Issuance of common stock $ 0 1,943 0 1,943
Issuance of common stock (in shares) 665,136      
Net loss $ 0 0 (2,122) (2,122)
Ending balance at Sep. 30, 2024 $ 4 $ 252,986 $ (243,647) $ 9,343
Ending balance (in shares) at Sep. 30, 2024 4,171,161